EE285 Cost-Effectiveness of Evolocumab Versus Standard Therapy for the Treatment of Dyslipidemia in Patients with Cardiovascular Disease in Qatar
Abstract
Authors
S AlMukdad R Kaddoura AR Arabi F AlMaraghi S Al-Saadi Al Yafei D Al-Badriyeh